Systemic illness of Connective tissue with progressive fibrosis of internal organs, obliterating vasculitis of small arteries
Diffuse disease of connective tissue with focal and systemic fibrosis of internal organs
Diffuse connective tissue disease, mainly affecting small vessels, joints, skin, kidneys and lungs
Diffuse disease of connective tissue with fibrous sclerotic changes in the skin and internal organs, vasculitis of small vessels in the form of obliterating endarteritis*
Systemic connective tissue disease with lesions of the skin, muscles, joints, involving in pathological process of internal organs
2002. By what name is registered systemic scleroderma in the international classification ICD10
systemic scleroderma
systemic scleroderma
systemic sclerosis*
lipodermatosclerosis
fibrous dermatitis
2003. What factors may be ejected to play a role in the etiology of systemic sclerosis
Infection of unknown RNA virus
Occupational ensure to polyvinyl chloride
Continuous operation under vibration
None of the above factors
All the above factors*
2004. What factors may play a role in the occurrence of systemic sclerosis
The presence of histocompatibility antigens HLA B35
The presence of histocompatibility antigens HLA Cw4
Chromosomal aberrations (chromatid breaks, ring chromosomes)
None of the above factors
All the above factors*
2005. For a type of scleroderma characterized by the appearance in the blood of specific antibodies to Scl70
The defeat of the skin at the beginning of the disease
All the abnormalities characteristic*
None of these abnormalities are not typical
2014. What are the pathological changes are not typical induratumsclerotic skin lesions in patients with systemic sclerosis
hyperemia, hot in the touching*
Dry, smooth and shiny
Is not taken into the fold
Junction with the underlying fascia, joint capsule, periosteum
No vellus hair
2015.What are the pathological changes are not characteristic of systemic sclerosis
Deformation of the fingernails
Telangiectasia on the skin
Pustular skin lesions
Light skin trauma with the formation of nonhealing ulcers
All the lesions are characteristic*
2016.What are the features of skin lesions are not typical of systemic sclerosis
Periorbital edema*
Radial folds around the mouth ("pouch")
Masklike face
Pointed nose ("bird's beak")
Outbreaks telangiectasia
2017.What's syndrome associated with the appearance of patients with systemic sclerosis dryness, lack of saliva in the mouth, inability to cry
Raynaud's Syndrome
Shegren's syndrome*
Jakko syndrome
TiberzheWeissenbach syndrome
CRESTsyndrome
2018.What's syndrome associated with the appearance of patients with systemic sclerosis attacks pallor, numbness of fingers, toes, ears, nose after eosure to cold
Jakko syndrome
TiberzheWeissenbach syndrome
CRESTsyndrome
Raynaud's syndrome*
Shegren's syndrome
2019.What forms of joint syndrome are typical of patients with systemic scleroderma
Poliarthralgia
Fibrosing arthritis of small joints of the fingers of the hands
2027.What are the blood count abnormalities characteristic of the acute form of the clinical course of systemic sclerosis with high activity of the pathological process
Increased ESR
Moderate leukocytosis
Mild hypochromic anemia
All the mentioned deviations are typical*
None of these abnormalities are not typical
2028.What are the abnormalities in the urine analysis are not typical of patients with systemic scleroderma
Proteinuria
Cylindruria
Reduction of specific gravity
Increase the excretion of hydroxyproline
Positive reaction to the BenceJones protein*
2029.What are the biochemical analysis of blood abnormalities are not typical of systemic sclerosis
increasing of fibrinogen
increasing of alpha2 and gamma globulin
increasing of the seromucoid, haptoglobins
increasing of the hydroxyproline content
All the mentioned deviations are typical*
2030.What is the immunological parameters specific to the diffuse form of systemic sclerosis
Autoantibodies to centromeres
Nuclear antibodies
Autoantibodies to Scl70*
All of the above
None of the above
2031.What are the deviations biopsy skinmuscle flap characteristic of systemic sclerosis
Obliterans small vessel vasculitis, fibrosclerotic changes in the structure of tissues*
Granulomatous vasculitis of small arteries, perivascular infiltration of tissues
Arthralgia and / or arthritis, adhesive pleurisy, cardio, ESR 2035 mm / hour
These laboratory results do not reflect the activity of the pathological process in this disease
2035.Which of the following indicators correspond to the II activity of systemic sclerosis
Fever, polyarthritis with erosive lesions, macrofocal or diffuse cardiosclerosis, mitral insufficiency, scleroderma kidney, ESR greater than 35 mm / h
Moderate trophic disorders, arthralgia, vasospastic Raynaud's syndrome, erythrocyte sedimentation rate 20 mm / h
Arthralgia and / or arthritis, adhesive pleurisy, cardio, ESR 2035 mm / hour*
The absence of laboratory abnormalities
These laboratory results do not reflect the activity of the pathological process in this disease
2036.Which of the following indicators correspond to the III activity of systemic sclerosis
Moderate trophic disorders, arthralgia, vasospastic Raynaud's syndrome, erythrocyte sedimentation rate 20 mm / h
Arthralgia and / or arthritis, adhesive pleurisy, cardio, ESR 2035 mm / hour
The absence of laboratory abnormalities
Fever, polyarthritis with erosive lesions, macrofocal or diffuse cardiosclerosis, mitral insufficiency, scleroderma kidney, ESR greater than 35 mm / h*
These laboratory results do not reflect the activity of the pathological process in this disease
2037.What medications appropriate to prescribe in diffuse form of SS with severe and severe systemic manifestations, the high activity of the pathological process
DPenicillamine
Kolhitsin
Hlorohin (Delagil)
Prednisolone*
All Indicated
2038.What drugs should be used in the treatment of systemic sclerosis for the symptomatic improvement of hemodynamics in the affected blood vessels and tissue structures
Nifedipine
Lisinopril
Glockenspiel
All the specified*
None of the above
2039.What methods are indicated for the topical treatment of systemic sclerosis
Applications Dimexidum solution to the affected skin